SCHEMBL30813386

SCHEMBL30813386

COc1ccc(CNc2ncnc3c2c(-c2ccc(N)c4nccn24)cn3C(C)C)c(OC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 17/20 0.41
▸ CYP3A4 P08684 17/20 0.41
▸ CYP2C19 P33261 17/20 0.41
▸ CYP2D6 P10635 15/20 0.41
▸ CLK4 Q9HAZ1 9/20 0.41
▸ CYP2C9 P11712 8/20 0.41
▸ TSHR P16473 14/20 0.40
▸ ALDH1A1 P00352 10/20 0.40
▸ MAPK1 P28482 5/20 0.40
▸ USP2 O75604 6/20 0.40
▸ LMNA P02545 7/20 0.40
▸ HIF1A Q16665 4/20 0.40
▸ MAPT P10636 1/20 0.40
▸ HSD17B10 Q99714 9/20 0.40
▸ ALOX15 P16050 5/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ CASP1 P29466 1/20 0.38
▸ CASP7 P55210 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27217633 1.00 CYP1A2 (0.41) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL30813319 0.90 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL27217742 0.90 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL27217743 0.80 SRC (0.41) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL27217801 0.80 CYP1A2 (0.37) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL21178740 0.78 CYP1A2 (0.47) CYP1A2CYP3A4CYP2C19CYP2D6CLK4
SCHEMBL30813537 0.78 SRC (0.48) MAPTMEN1KMT2A
SCHEMBL27217722 0.78 SRC (0.48) MAPTMEN1KMT2A
SCHEMBL30813528 0.76 BRAF (0.40) CYP1A2CYP3A4CYP2C19
SCHEMBL27217940 0.76 BRAF (0.40) CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059200-A1 NEK7 INHIBITORS Halia Therapeutics, Inc. (US) 2024-03-21 — — WO disclosed
Send feedback